Page last updated: 2024-08-24

colestipol and niacin

colestipol has been researched along with niacin in 72 studies

Research

Studies (72)

Timeframe	Studies, this research(%)	All Research%
pre-1990	30 (41.67)	18.7374
1990's	35 (48.61)	18.2507
2000's	7 (9.72)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azen, SP; Blankenhorn, DH; Crawford, DW; Lee, PL; Mack, WJ; Pogoda, J; Selzer, RH; Shircore, AM	1
McIntyre, TH; Shapiro, ML; Whitney, EJ; Wirebaugh, SR	1
Azen, SP; Blankenhorn, DH; Lee, PL; Mack, WJ; Pogoda, JM; Selzer, RH; Shircore, AM	1
Brown, BG	1
Azen, SP; Blankenhorn, DH; Crawford, DW; Nessim, SA; Sanmarco, ME; Selzer, RH; Shircore, AM; Wickham, EC	1
Eisenberg, JM; Glick, H; Jacobson, TA; Kinosian, B; Koffer, H; Schulman, KA; Willian, MK	1
Albers, JJ; Bisson, BD; Brown, G; Dodge, HT; Fisher, LD; Fitzpatrick, VF; Kaplan, C; Lin, JT; Schaefer, SM; Zhao, XQ	1
Diehl, JC; Havel, RJ; Kane, JP; Malloy, MJ; Phillips, NR; Ports, TA	1
Azen, SP; Blankenhorn, DH; Cashin-Hemphill, L; Mack, WJ; Pogoda, JM; Sanmarco, ME	1
Adams, M; Dell, RB; Goldberg, IJ; Goodman, DS; Holleran, S; Palmer, RH; Ramakrishnan, R	1
Bacon, SP; Cope, R; Illingworth, DR	1
Alaupovic, P; Azen, SP; Blankenhorn, DH; Chin, HP; Wickham, E	1
Anding, RH; Lueg, MC	1
Blankenhorn, DH; Cashin-Hemphill, L; Chin, HP; Lee, NA; Nessim, SA; Nicoloff, JT; Spencer, CA	1
Hunninghake, DB	1
Kane, JP; Malloy, MJ	2
Azen, SP; Blankenhorn, DH; Cashin-Hemphill, L; Johnson, RL; Nessim, SA; Sanmarco, ME	1
Naito, HK	1
Azen, SP; Blankenhorn, DH; Johnson, RL; Nessim, SA; Sanmarco, ME; Selzer, RH	1
Stein, EA	1
Davignon, J	1
Blum, CB; Levy, RI	1
Nikkilä, EA; Tikkanen, MJ	1
Havel, RJ; Kane, JP	2
Gotto, AM; Jones, PH; Scott, LW	1
Packard, CJ; Shepherd, J	1
Roberts, L	1
Kane, JP; Kunitake, ST; Malloy, MJ; Tun, P	1
Bassett, D; Gross, MD; Lynn, MD; Shapiro, B	1
Levy, RI; Schaefer, EJ	1
Parker, F	1
Azen, SP; Blankenhorn, DH; Nessim, SA	1
Stamler, J	1
Nash, DT	1
Glueck, CJ	1
Azarnoff, DL; Saunders, RN	1
Kostis, JB; Kuo, PT; Moreyra, AE	1
Azen, SP; LaBree, L; Lapuerta, P	1
Ginsberg, HN	1
Albers, JJ; Brown, BG; Hillger, L; Poulin, D; Zhao, XQ	1
Chin, MM; Jozefiak, E; Morales, E; Spinler, SA; Wilson, MD	1
Farmer, JA; Gotto, AM	2
Albers, JJ; Brown, BG; Dowdy, A; Fisher, LD; Hillger, LA; Sniderman, AD; Stewart, BF; Zhao, XQ	1
Hathaway, SC; Paat, JJ; Paterson, RW; Steele, GH; Wong, JG	1
Blankenhorn, DH; Crawford, DW; Erickson, JK; Hodis, HN; Liu, CH; Liu, CR; Mack, WJ; Selzer, RH	1
Albers, JJ; Bisson, B; Brown, BG; Fisher, L; Hillger, L; Sacco, D; Zhao, XQ	1
Alaupovic, P; Barth, JD; Blankenhorn, DH; Crawford, DW; Liu, CH; Liu, CR; Mack, WJ; Selzer, RH	1
McKenney, JM	1
Coates, PM; Cortner, JA; Jarvik, GP; Liacouras, CA	1
Azen, SP; Blankenhorn, DH; Cashin-Hemphill, L; Hodis, HN; LaBree, L; Mack, WJ; Selzer, RH; Shircore, AM	1
Hiatt, J; Schectman, G	1
Hodis, HN	1
Bambauer, R; Müller, UA; Schiel, R	1
Avery, BR	1
Albers, JJ; Bardsley, J; Brown, BG; Dowdy, A; Hillger, LA; Knopp, RH; Maher, VM; Poulin, D; Zhao, XQ	1
Albers, JJ; Brown, BG; Brunzell, JD; Davis, JW; Maher, VM; Poulin, D; Rocha, A; Zambon, A	1
Brown, BG; Brunzell, JD; Hokanson, JE; Zambon, A	1
Hodis, HN; Mack, WJ; Selzer, RH; Xiang, M	1
Hodis, HN; LaBree, L; Liu, C; Mack, WJ; Selzer, RH	1
Azen, SP; Hodis, HN; Mack, WJ; Selzer, RH; Shircore, AM; Xiang, M	1
Brown, BG; Brunzell, JD; Deeb, SS; Hokanson, JE; Zambon, A	1
Piepho, RW	1
Brown, BG; Brunzell, JD; Hokanson, JE; Motulsky, AG; Zambon, A	1

Reviews

17 review(s) available for colestipol and niacin

Article	Year
Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management. JAMA, 1990, Dec-19, Volume: 264, Issue:23 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Cost-Benefit Analysis; Drug Therapy, Combination; Gemfibrozil; Humans; Hypercholesterolemia; Lovastatin; Niacin; Probucol; Sensitivity and Specificity	1990
When to treat hyperlipidemia. Advances in internal medicine, 1988, Volume: 33 Topics: Animals; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Neomycin; Niacin; Pentanoic Acids; Risk Factors; Triglycerides	1988
Reducing cardiac deaths with hypolipidemic drugs. Postgraduate medicine, 1987, Nov-01, Volume: 82, Issue:6 Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Feeding Behavior; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins, LDL; Niacin; Patient Education as Topic; Pentanoic Acids; Probucol	1987
Treatment of hypercholesterolemia. Annual review of medicine, 1986, Volume: 37 Topics: Animals; Cholestyramine Resin; Clofibrate; Colestipol; Cricetinae; Dogs; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Mice; Middle Aged; Neomycin; Niacin; Pentanoic Acids; Pregnancy; Probucol; Rats	1986
The diagnosis and management of hyperlipidemia. Disease-a-month : DM, 1986, Volume: 32, Issue:5 Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides	1986
Pharmacological modification of lipoprotein metabolism. Biochemical Society transactions, 1987, Volume: 15, Issue:2 Topics: Animals; Bile Acids and Salts; Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Intestinal Absorption; Lipoproteins; Niacin; Sterols	1987
Pathogenesis and management of lipoprotein disorders. The New England journal of medicine, 1985, May-16, Volume: 312, Issue:20 Topics: Abetalipoproteinemia; Adolescent; Adult; Aged; Child; Child, Preschool; Cholestyramine Resin; Chylomicrons; Colestipol; Dietary Fats; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Hyperlipoproteinemias; Hypobetalipoproteinemias; Hypolipoproteinemias; Infant; Infant, Newborn; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Niacin; Pentanoic Acids; Probucol; Tangier Disease	1985
Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis. Annals of internal medicine, 1982, Volume: 96, Issue:4 Topics: Arteriosclerosis; Cholesterol; Colestipol; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Niacin; Nicotinic Acids; Phenols; Polyamines; Probucol	1982
Treatment of hypercholesterolemia. The Medical clinics of North America, 1982, Volume: 66, Issue:2 Topics: Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Heterozygote; Homozygote; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols; Thyroxine	1982
Therapy of hyperlipidemic states. Annual review of medicine, 1982, Volume: 33 Topics: Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Colestipol; Dietary Fats; Drug Therapy, Combination; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Lipoproteins, LDL; Lipoproteins, VLDL; Niacin; Nicotinic Acids; Sitosterols	1982
Current status of drugs used to treat hyperlipoproteinemias. Drug therapeutics, 1982 Topics: Aminosalicylic Acid; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Enzyme Induction; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols	1982
Update on the treatment of hypercholesterolemia, with a focus on HMG-CoA reductase inhibitors and combination regimens. Clinical cardiology, 1995, Volume: 18, Issue:6 Topics: Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Coronary Disease; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Niacin	1995
Antihyperlipidaemic agents. Drug interactions of clinical significance. Drug safety, 1994, Volume: 11, Issue:5 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibric Acid; Colestipol; Drug Interactions; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Niacin; Probucol	1994
Impact of intensive lipid modulation on angiographically defined coronary disease: clinical implications. Southern medical journal, 1994, Volume: 87, Issue:2 Topics: Angiography; Clinical Trials as Topic; Colestipol; Coronary Disease; Humans; Hypercholesterolemia; Lipids; Lovastatin; Niacin; Random Allocation	1994
Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management. The Journal of pediatrics, 1993, Volume: 123, Issue:2 Topics: Adolescent; Apolipoproteins B; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Energy Intake; Female; Genetic Linkage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Lipoproteins, VLDL; Liver; Male; Multigene Family; Niacin; Phenotype; Polymorphism, Genetic; Triglycerides	1993
Choosing the right lipid-regulating agent. A guide to selection. Drugs, 1996, Volume: 52, Issue:5 Topics: Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Niacin; Triglycerides	1996
Use of niacin, statins, and resins in patients with combined hyperlipidemia. The American journal of cardiology, 1998, Feb-26, Volume: 81, Issue:4A Topics: Anticholesteremic Agents; Apolipoproteins; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Cohort Studies; Colestipol; Coronary Disease; Drug Therapy, Combination; Humans; Hyperlipidemia, Familial Combined; Hypolipidemic Agents; Lovastatin; Niacin; Risk Factors; Triglycerides	1998

Trials

27 trial(s) available for colestipol and niacin

Article	Year
Comparison of computer- and human-derived coronary angiographic end-point measures for controlled therapy trials. Arteriosclerosis and thrombosis : a journal of vascular biology, 1992, Volume: 12, Issue:3 Topics: Adult; Colestipol; Combined Modality Therapy; Computers; Coronary Angiography; Coronary Artery Disease; Humans; Male; Middle Aged; Niacin	1992
Effect of lovastatin or niacin combined with colestipol and regression of coronary atherosclerosis. European heart journal, 1992, Volume: 13 Suppl B Topics: Apolipoprotein A-I; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Coronary Angiography; Coronary Artery Disease; Drug Therapy, Combination; Humans; Lovastatin; Male; Middle Aged; Niacin	1992
Effects of colestipol-niacin therapy on human femoral atherosclerosis. Circulation, 1991, Volume: 83, Issue:2 Topics: Arteriosclerosis; Cholesterol, Dietary; Cholesterol, LDL; Colestipol; Combined Modality Therapy; Coronary Artery Bypass; Femoral Artery; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Niacin; Radiography	1991
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. The New England journal of medicine, 1990, Nov-08, Volume: 323, Issue:19 Topics: Adult; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Coronary Angiography; Coronary Disease; Diet; Double-Blind Method; Drug Therapy, Combination; Humans; Lovastatin; Male; Middle Aged; Multivariate Analysis; Niacin	1990
Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA, 1990, Dec-19, Volume: 264, Issue:23 Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Coronary Artery Disease; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Niacin; Radiographic Image Interpretation, Computer-Assisted; Triglycerides	1990
Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up. JAMA, 1990, Dec-19, Volume: 264, Issue:23 Topics: Adult; Apolipoproteins; Cholesterol; Colestipol; Coronary Artery Disease; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Niacin; Radiography	1990
Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation, 1990, Volume: 81, Issue:2 Topics: Apolipoprotein C-III; Apolipoproteins; Apolipoproteins C; Colestipol; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Humans; Lipids; Male; Middle Aged; Multivariate Analysis; Niacin; Randomized Controlled Trials as Topic; Recurrence	1990
Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA, 1987, Jun-19, Volume: 257, Issue:23 Topics: Adult; Clinical Trials as Topic; Colestipol; Coronary Artery Bypass; Coronary Artery Disease; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans; Lipids; Male; Middle Aged; Niacin; Polyamines; Radiography; Random Allocation	1987
The Cholesterol Lowering Atherosclerosis Study (CLAS): design, methods, and baseline results. Controlled clinical trials, 1987, Volume: 8, Issue:4 Topics: Adult; Angiography; Arteriosclerosis; California; Cholesterol, Dietary; Cholesterol, LDL; Clinical Trials as Topic; Colestipol; Dietary Fats; Humans; Male; Middle Aged; Niacin; Prospective Studies; Random Allocation; Research Design	1987
Treatment of hyperlipidaemia and progression of atherosclerosis. Lancet (London, England), 1983, Nov-19, Volume: 2, Issue:8360 Topics: Adult; Arteriosclerosis; Colestipol; Double-Blind Method; Female; Humans; Hyperlipidemias; Middle Aged; Niacin	1983
Pharmacological trials: primary and secondary prevention of coronary heart disease. Preventive medicine, 1983, Volume: 12, Issue:1 Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dipyridamole; Estrogens; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Sulfinpyrazone	1983
Current status of drugs used to treat hyperlipoproteinemias. Drug therapeutics, 1982 Topics: Aminosalicylic Acid; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Enzyme Induction; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols	1982
Types of change in coronary stenosis severity and their relative importance in overall progression and regression of coronary disease. Observations from the FATS Trial. Familial Atherosclerosis Treatment Study. Annals of the New York Academy of Sciences, 1995, Jan-17, Volume: 748 Topics: Adult; Colestipol; Coronary Disease; Diet, Fat-Restricted; Humans; Lovastatin; Male; Middle Aged; Niacin	1995
Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol. Journal of the American College of Cardiology, 1994, Mar-15, Volume: 23, Issue:4 Topics: Adult; Analysis of Variance; Anticholesteremic Agents; Apolipoproteins B; Cholesterol, LDL; Colestipol; Coronary Angiography; Coronary Disease; Double-Blind Method; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Niacin; Treatment Outcome	1994
One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol/niacin therapy. Stroke, 1993, Volume: 24, Issue:12 Topics: Adult; Arteriosclerosis; Carotid Arteries; Colestipol; Humans; Lipids; Longitudinal Studies; Male; Middle Aged; Niacin; Tunica Intima; Tunica Media	1993
Effects of intensive lipid-lowering therapy on the coronary arteries of asymptomatic subjects with elevated apolipoprotein B. Circulation, 1993, Volume: 88, Issue:6 Topics: Adult; Apolipoproteins B; Colestipol; Coronary Disease; Coronary Vessels; Double-Blind Method; Exercise Test; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Niacin; Radiography	1993
Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation, 1993, Volume: 88, Issue:1 Topics: Adult; Arteriosclerosis; Carotid Artery Diseases; Carotid Artery, Common; Colestipol; Drug Therapy, Combination; Humans; Image Processing, Computer-Assisted; Lipids; Male; Middle Aged; Niacin; Pilot Projects; Ultrasonography	1993
Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study. Circulation, 1996, Jan-01, Volume: 93, Issue:1 Topics: Adult; Colestipol; Coronary Angiography; Coronary Artery Disease; Diet, Fat-Restricted; Follow-Up Studies; Humans; Hypolipidemic Agents; Male; Middle Aged; Niacin; Predictive Value of Tests	1996
Reversibility of atherosclerosis--evolving perspectives from two arterial imaging clinical trials: the cholesterol lowering atherosclerosis regression study and the monitored atherosclerosis regression study. Journal of cardiovascular pharmacology, 1995, Volume: 25 Suppl 4 Topics: Angiography; Arteriosclerosis; Carotid Arteries; Carotid Artery Injuries; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Coronary Artery Bypass; Coronary Vessels; Dose-Response Relationship, Drug; Female; Femoral Artery; Humans; Hypolipidemic Agents; Image Processing, Computer-Assisted; Male; Niacin; Sex Factors; Treatment Outcome; Ultrasonography	1995
Four years' treatment efficacy of patients with severe hyperlipidemia. Lipid lowering drugs versus LDL-apheresis. The International journal of artificial organs, 1995, Volume: 18, Issue:12 Topics: Adolescent; Adult; Anticholesteremic Agents; Blood Component Removal; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Longitudinal Studies; Lovastatin; Male; Middle Aged; Niacin; Pravastatin; Quality of Life	1995
Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100 mg/dl in patients with hyperlipidemia and coronary artery disease. The American journal of cardiology, 1997, Jul-15, Volume: 80, Issue:2 Topics: Cholesterol, LDL; Colestipol; Cross-Over Studies; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Hyperlipidemias; Lovastatin; Male; Middle Aged; Niacin; Patient Compliance	1997
Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. Circulation, 1999, Apr-20, Volume: 99, Issue:15 Topics: Aged; Anticholesteremic Agents; Apolipoproteins B; Centrifugation, Density Gradient; Chemical Phenomena; Chemistry, Physical; Cholesterol, LDL; Colestipol; Combined Modality Therapy; Coronary Artery Disease; Drug Therapy, Combination; Humans; Hypolipidemic Agents; Lipase; Lipids; Lipolysis; Lipoproteins; Liver; Lovastatin; Male; Middle Aged; Niacin	1999
Serial quantitative coronary angiography and coronary events. American heart journal, 2000, Volume: 139, Issue:6 Topics: Adult; Cholesterol, LDL; Colestipol; Collateral Circulation; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Death, Sudden, Cardiac; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Niacin; Prognosis; Proportional Hazards Models	2000
Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography. Atherosclerosis, 2000, Volume: 150, Issue:2 Topics: Adult; Carotid Artery, Common; Carotid Stenosis; Colestipol; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Male; Middle Aged; Niacin; Observer Variation; Prognosis; Reproducibility of Results; Tunica Intima; Ultrasonography; Video Recording	2000
Efficacy of two lipid-lowering treatments on quantitative coronary angiographic endpoints. Cardiovascular drugs and therapy, 2000, Volume: 14, Issue:4 Topics: Adult; Aged; Anticholesteremic Agents; Arteriosclerosis; Colestipol; Coronary Angiography; Drug Combinations; Female; Humans; Hypolipidemic Agents; Longitudinal Studies; Lovastatin; Male; Middle Aged; Niacin; Randomized Controlled Trials as Topic; Sensitivity and Specificity	2000
Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment. Circulation, 2001, Feb-13, Volume: 103, Issue:6 Topics: Analysis of Variance; Cholesterol, HDL; Colestipol; Coronary Angiography; Coronary Disease; Drug Therapy, Combination; Genotype; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipase; Lipoproteins, HDL; Lipoproteins, LDL; Liver; Lovastatin; Male; Middle Aged; Niacin; Polymerase Chain Reaction; Polymorphism, Genetic; Prognosis; Promoter Regions, Genetic; Regression Analysis	2001
Genetically determined apo B levels and peak LDL density predict angiographic response to intensive lipid-lowering therapy. Journal of internal medicine, 2006, Volume: 259, Issue:4 Topics: Adult; Analysis of Variance; Apolipoproteins B; Colestipol; Coronary Angiography; Coronary Stenosis; Drug Therapy, Combination; Dyslipidemias; Genetic Predisposition to Disease; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins, LDL; Lovastatin; Male; Middle Aged; Niacin; Pharmacogenetics; Treatment Outcome	2006

Other Studies

29 other study(ies) available for colestipol and niacin

Article	Year
Evaluation of colestipol/niacin therapy with computer-derived coronary end point measures. A comparison of different measures of treatment effect. Circulation, 1992, Volume: 86, Issue:6 Topics: Adult; Colestipol; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Vessels; Drug Therapy, Combination; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Niacin; Randomized Controlled Trials as Topic; Treatment Outcome	1992
A retrospective review of the use of lipid-lowering agents in combination, specifically, gemfibrozil and lovastatin. Pharmacotherapy, 1992, Volume: 12, Issue:6 Topics: Aged; Alanine Transaminase; Cholestyramine Resin; Colestipol; Creatine Kinase; Drug Interactions; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Lipids; Lovastatin; Male; Middle Aged; Niacin; Retrospective Studies	1992
Choice of cholesterol-lowering drugs. The Medical letter on drugs and therapeutics, 1991, Jan-11, Volume: 33, Issue:835 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Lovastatin; Neomycin; Niacin; Probucol	1991
Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism. The Journal of clinical investigation, 1990, Volume: 86, Issue:3 Topics: Adult; Aged; Cholesterol; Colestipol; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Metabolic Clearance Rate; Middle Aged; Niacin	1990
Regression of tendon xanthomas in patients with familial hypercholesterolemia treated with lovastatin. Southern medical journal, 1990, Volume: 83, Issue:9 Topics: Achilles Tendon; Adult; Cholesterol, LDL; Colestipol; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Niacin; Radiography; Remission Induction; Tendons; Wolman Disease	1990
Hypercholesterolemia: new values, new strategies. Hospital practice (Office ed.), 1986, Jan-30, Volume: 21, Issue:1A Topics: Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Colestipol; Coronary Disease; Energy Intake; Female; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Niacin	1986
Alterations in serum thyroid hormonal indices with colestipol-niacin therapy. Annals of internal medicine, 1987, Volume: 107, Issue:3 Topics: Adult; Arteriosclerosis; Colestipol; Drug Therapy, Combination; Humans; Lipids; Male; Middle Aged; Niacin; Polyamines; Thyroid Hormones; Thyroxine; Thyroxine-Binding Proteins	1987
Current and new therapy for hypercholesterolemia. The Journal of the American Osteopathic Association, 1988, Volume: 88, Issue:7 Topics: Anticholesteremic Agents; Colestipol; Gemfibrozil; Humans; Hypercholesterolemia; Lovastatin; Niacin; Probucol	1988
Drug therapy in children and adolescents with familial hypercholesterolemia. Progress in clinical and biological research, 1988, Volume: 255 Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Infant; Male; Niacin	1988
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. Archives of internal medicine, 1988, Volume: 148, Issue:1 Topics: Adult; Aged; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Coronary Disease; Dietary Fats; Female; Gemfibrozil; Humans; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Male; Middle Aged; Niacin; Patient Compliance; Pentanoic Acids; Probucol; Risk Factors	1988
Medical management of hyperlipidemia and the role of probucol. The American journal of cardiology, 1986, Jun-27, Volume: 57, Issue:16 Topics: Adult; Arteriosclerosis; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Female; Gemfibrozil; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Niacin; Pentanoic Acids; Phenols; Probucol; Risk	1986
Rational drug therapy of the hyperlipoproteinemias, Part II. Rational drug therapy, 1986, Volume: 20, Issue:10 Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Female; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Probucol	1986
Current pharmacologic treatment of elevated serum cholesterol. Circulation, 1987, Volume: 76, Issue:3 Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Drug Tolerance; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Probucol; Simvastatin; Triglycerides	1987
Study bolsters case against cholesterol. Science (New York, N.Y.), 1987, Jul-03, Volume: 237, Issue:4810 Topics: Adult; Arteriosclerosis; Cholesterol; Colestipol; Dietary Fats; Humans; Male; Middle Aged; Niacin	1987
Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia. Annals of internal medicine, 1987, Volume: 107, Issue:5 Topics: Adult; Aged; Apolipoproteins B; Cholesterol; Cholesterol, LDL; Colestipol; Drug Therapy, Combination; Female; Heterozygote; Homozygote; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Niacin; Polyamines	1987
Colestipol-niacin therapy and coronary atherosclerosis. JAMA, 1987, Nov-20, Volume: 258, Issue:19 Topics: Adult; Colestipol; Coronary Artery Disease; Humans; Male; Middle Aged; Niacin; Polyamines; Research Design	1987
The influence of hypercholesterolaemia on the adrenal uptake and metabolic handling of 131I-6 beta-iodomethyl-19-norcholesterol (NP-59). Nuclear medicine communications, 1986, Volume: 7, Issue:8 Topics: 19-Iodocholesterol; Adrenal Cortex; Animals; Bile; Cholesterol; Colestipol; Disease Models, Animal; Esters; Humans; Hypercholesterolemia; Iodine Radioisotopes; Male; Niacin; Rabbits; Radionuclide Imaging; Triglycerides	1986
Lipid-lowering drugs. The Medical letter on drugs and therapeutics, 1985, Aug-30, Volume: 27, Issue:695 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Neomycin; Niacin; Pentanoic Acids; Probucol; Triglycerides	1985
Xanthomas and hyperlipidemias. Journal of the American Academy of Dermatology, 1985, Volume: 13, Issue:1 Topics: Apoproteins; Arteriosclerosis; Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Diabetes Complications; Female; Humans; Hyperlipidemias; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Hypolipidemic Agents; Hypothyroidism; Kidney Diseases; Lipoproteins; Male; Neomycin; Niacin; Obesity; Pancreatitis; Xanthomatosis	1985
Gemfibrozil in combination with other drugs for severe hyperlipidemia. Preliminary study comprising four cases. Postgraduate medicine, 1983, Volume: 73, Issue:4 Topics: Adult; Cholesterol; Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipidemias; Lipoproteins, HDL; Male; Middle Aged; Niacin; Pentanoic Acids; Probucol; Triglycerides; Valerates	1983
Protection of myocardium by the compensatory mechanism of coronary collaterals after total occlusion of major coronary arteries shown in patients with familial hypercholesterolemia. American heart journal, 1982, Volume: 104, Issue:1 Topics: Adult; Arterial Occlusive Diseases; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Colestipol; Coronary Circulation; Coronary Disease; Electrocardiography; Female; Heart; Heart Function Tests; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Middle Aged; Niacin; Nicotinic Acids; Radiography; Radionuclide Imaging	1982
Use of neural networks in predicting the risk of coronary artery disease. Computers and biomedical research, an international journal, 1995, Volume: 28, Issue:1 Topics: Adult; Cholesterol; Colestipol; Coronary Artery Disease; Coronary Disease; Diet, Fat-Restricted; Follow-Up Studies; Forecasting; Humans; Lipids; Lipoproteins; Longitudinal Studies; Male; Middle Aged; Neural Networks, Computer; Niacin; Placebos; Randomized Controlled Trials as Topic; Regression Analysis; Reproducibility of Results; Risk Factors	1995
Criteria for use of hypolipidemic agents in adults. American journal of hospital pharmacy, 1994, Nov-15, Volume: 51, Issue:22 Topics: Adult; Anticholesteremic Agents; Cholestyramine Resin; Colestipol; Female; Gemfibrozil; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Niacin; Risk Factors	1994
New guidelines for managing hypercholesterolemia. National Cholesterol Education Program. American pharmacy, 1993, Volume: NS33, Issue:7 Topics: Algorithms; Anticholesteremic Agents; Cholestyramine Resin; Colestipol; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Oxidoreductases; Risk Factors	1993
Choice of cholesterol-lowering drugs. The Medical letter on drugs and therapeutics, 1993, Mar-05, Volume: 35, Issue:891 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Probucol	1993
Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals. The American journal of medicine, 1996, Volume: 100, Issue:2 Topics: Aged; Anticholesteremic Agents; Cholesterol, LDL; Colestipol; Coronary Disease; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Niacin; Peripheral Vascular Diseases; Retrospective Studies; Treatment Outcome; Triglycerides	1996
Treatment of the patient with primary familial heterozygous hypercholesterolemia. The Journal of cardiovascular nursing, 1995, Volume: 9, Issue:2 Topics: Aged; Colestipol; Coronary Disease; Diet, Fat-Restricted; Drug Therapy, Combination; Exercise; Female; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Niacin; Patient Compliance; Weight Loss	1995
The pharmacokinetics and pharmacodynamics of agents proven to raise high-density lipoprotein cholesterol. The American journal of cardiology, 2000, Dec-21, Volume: 86, Issue:12A Topics: Biological Availability; Cholesterol; Cholesterol, HDL; Colestipol; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Liver; Niacin	2000
Complementary care. How statin alternatives stack up. Some help control cholesterol; others are potentially harmful. Heart advisor, 2005, Volume: 8, Issue:1 Topics: Anticholesteremic Agents; Cholestyramine Resin; Colestipol; Fatty Alcohols; Humans; Niacin; Phytotherapy; Psyllium	2005